Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study. D'Haens GR, Lowenberg M, Baert F, Bossuyt P, et al. Lancet Gastroenterol Hepatol 2025 Oct 27:S2468-1253(25)00233.

Read + Share

Amedeo Smart

Independent Medical Education

D'Haens GR, Lowenberg M, Baert F, Bossuyt P, et al. Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study. Lancet Gastroenterol Hepatol 2025 Oct 27:S2468-1253(25)00233.
PMID: 41167233